[ngopharmacy-blog]

MedPharm at the 2011 World Health Summit.

[ngopharmacy-blog]

Outstanding Commitment to Deworming Recognized in Berlin

MedPharm has long been a standing innovator and leader in the fight against Neglected Tropical Diseases; particularly against Schistosomiasis and Soil transmitted helminthiasis. Recently, MedPharm had this contribution recognized at the World Health Summit held in Berlin, Germany.  Members of MedPharm were on hand to take part in a symposium discussing the “Opportunities for Linking NTD Control with Control of AIDS, Tuberculosis and Malaria” 

http://www.worldhealthsummit.org

[ngopharmacy-blog]

MedPharm attends innovative new Global Humanitarian Aid Event

AidEx 2011 brought the international aid community together to source solutions to discuss and improve the efficiency of aid delivery.  AidEx 2011 was a great success, with hundreds of humanitarian aid professionals gathering in Brussels over two days to share experiences, network and source ideas The launch event took place on 19-20 October 2011 at the Brussels Expo, and saw NGOs, charities, government organizations together to meet with suppliers and discuss ways to practically improve aid delivery by working together. http://www.aid-expo.com/en

[ngopharmacy-blog]

Symposiums and Supply Chains

 MedPharm CEO Andrew Koval continues his current round of negotiations and meetings in Europe’s pharmaceutical and humanitarian capitals.

After spending time visiting and inspecting logistic partners in the Netherlands, Mr. Koval went on to the United Kingdom, where he was to attend the Partnership for Disease Control Initiatives Round Table discussions. Then on to Italy where he met with product suppliers and partners before traveling to Switzerland for meetings with World Health Organization officials.

[ngopharmacy-blog]

Update on Africa

The drought in the Horn of Africa is arguably the worst in recent history. In Ethiopia, Kenya, Somalia and Djibouti, more than 13 million people are in need of assistance. In Somalia, famine has spread through large areas of the south. Three-quarters of a million men, women and children are at imminent risk of starvation; 4 million need urgent help.  Tens of thousands of refugees have moved to Mogadishu, overwhelming its limited infrastructure. Tens of thousands more have crossed the border to overcrowded camps in neighboring countries. Meanwhile, millions of people in Kenya, Ethiopia and Djibouti continue to face severe difficulties.

MedPharm, in cooperation with our NGO partners, has pledged pharmaceutical aid valued at $1 million USD towards the relief of the acute medical crisis. MedPharm CEO Andrew Koval commented, “We continue to work with our partners in providing critically needed essential medicines that we hope bring a margin of liberation to this ravaged region."

[ngopharmacy-blog]

MedPharm Introduces Quality Assurance Program

Since MedPharm's inception in 1994, we have been committed to the highest level of quality and purity in the pharmaceutical industry. With the introduction of our own family of products, we are proud to announce our Quality Assurance program. The MedPharm Quality Assurance “Q” seal on the package guarantees that our product has been screened and meets the highest quality standards as set by BP or USP, and that it has been manufactured in accordance with good manufacturing procedures.

[ngopharmacy-blog]

Testing New Innovative Deworming Solutions

Initial trials are encouraging for MedPharm supplied Nitezole. Developed with the goal of increasing the success of deworming programs worldwide, this product introduces a single-dose tablet that combines one wide spectrum deworming product, Mebendazole, with one antiprotozoal product, Tinidazole. These combinations are effective against macroscopic parasites such as oxiuros, ascaris lumbricoides, ancylostoma duodenale, necator americanus, trichuris, and tenia; and also for microscopic parasites, tricomonas, and amebas, plus a principal and most effective agent to treat Giardia.

The trials are being conducted through a consortium of partners across twelve countries and with the goal of treating 4.5 million children.

[ngopharmacy-blog]

Earthquake Update

Reports indicate that a 5.8 magnitude earthquake occurred in Virginia at 1:51 pm EDT on August 23, 2011. MedPharm evacuated its premises and closed its head office as a precautionary measure. All of MedPharm’s staff are safe and unharmed. MedPharm facilities, including our on-site laboratory facilities, suffered no damages.  Operations have resumed as usual. Thank you to all of our clients and friends who expressed concern for our wellbeing.

[ngopharmacy-blog]

Swaziland's MOH Extends Invitation to MedPharm

MedPharm has been invited to prequalify to tender to Swaziland's Ministry of Health.  We see this as a strong validation of our international reputation, and look forward to the opportunity to demonstrate the high commitment to service and quality that MedPharm demonstrates in all of its endeavors.

[ngopharmacy-blog]

Investing in Common Solutions

MedPharm senior members and development officers spent several days last week attending and networking at the InterAction 2011 Forum held in Washington, DC. The Forum brings together stakeholders from all levels of the NGO universe, along with Corporate CEOs and Nobel Laureates, to promote innovative solutions to common issues. MedPharm has been a long standing supporter and member of such events and is proud to continue being involved. InterAction is the largest alliance of U.S.-based international nongovernmental organizations (NGOs), with more than 190 members working in every developing country.  Members are faith-based and secular, large and small, with a focus on the world’s most poor and vulnerable populations.

www.interaction.org

[ngopharmacy-blog]

MedPharm Attends China Conference

MedPharm executives recently attended the CPHi China trade show in Shanghai, China. With over 1,700 exhibitors this is the preeminent pharmaceutical event in the region. After three successful days of meetings and negotiations, we were able to enhance our portfolio with several new and innovative products.

[ngopharmacy-blog]

MedPharm CEO Andrew Koval distributing Praziquental in Madagascar.

[ngopharmacy-blog]

MedPharm reaffirms its commitment to Madagascar

MedPharm recently pledged its continued support of Madagascar’s Comprehensive Plan to Control Neglected Tropical Diseases, now in its third year. Under the guidance of the Government of Madagascar, this broad reaching program is the result of the combined efforts of the World Health Organization (WHO), Merck of Germany, GlaxoSmithKline of the United Kingdom and MedPharm.

[ngopharmacy-blog]

New Strategic Partnership with FDA Imports

MedPharm is proud to introduce our newest partner, FDA Imports. Bringing extensive import and regulatory experience, FDA Imports is uniquely qualified to deliver to MedPharm clients the necessary guidance when dealing with the FDA. With offices in both the United States and China, the addition of FDA Imports continues to build on MedPharm’s expanding infrastructure into the global pharmaceutical arena.

[ngopharmacy-blog]

MedPharm is the proud recipient of the United States Department of Commerce Export Achievement Certificate, for our "Accomplishments in the Global Marketplace." You can learn more about the DOC at http://www.commerce.gov

[ngopharmacy-blog]

New website for deworm the world.

Learn more about our own deworming program at http://ngopharmacy.com/deworming_donation_program.php

[ngopharmacy-blog]

NGO Pharmacy attends the Aid & International Development Forum

Yesterday, members of the MedPharm and NGO Pharmacy team attended the Aid & International Development Forum in Washington, DC, which focuses on humanitarian operations.

http://www.aidforumonline.org

While there, MedPharm CEO Andrew Koval was interviewed by a film crew for an upcoming documentary on NGO and private sector partnerships. We'll have more on that when it becomes available.